THU133 Inpatient Hypoglycemia Management: Error Rates In Pediatric Diabetes Care
Disclosure: D.A. Odutayo: None. E.M. Rizzi: None. N. Allen: None. Hypoglycemia is a known side effect of exogenous insulin. During severe hypoglycemia, children with diabetes treated with insulin risk neurodevelopmental sequelae as protective glycolysis and ketogenesis are suppressed. Rapid treatmen...
Gespeichert in:
Veröffentlicht in: | Journal of the Endocrine Society 2023-10, Vol.7 (Supplement_1) |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosure: D.A. Odutayo: None. E.M. Rizzi: None. N. Allen: None.
Hypoglycemia is a known side effect of exogenous insulin. During severe hypoglycemia, children with diabetes treated with insulin risk neurodevelopmental sequelae as protective glycolysis and ketogenesis are suppressed. Rapid treatment of hypoglycemia is crucial to prevent deleterious effects on neurocognition. There is a paucity of data elucidating inpatient hypoglycemia incidence and adherence to treatment standards in hospital care. The goal of this study is to assess the rate of hypoglycemia in children and adolescents with diabetes in the inpatient setting, and to assess adherence to American Diabetes Association (ADA) standards of care in treatment of hypoglycemia. Hypoglycemia is defined as blood glucose ≤ 70 mg/dL in children ≥5 years old, and ≤ 80 mg/dL in children |
---|---|
ISSN: | 2472-1972 2472-1972 |
DOI: | 10.1210/jendso/bvad114.1385 |